Immunogenicity, reactogenicity and #safety to assess #booster #vaccinations with #BNT162b2 or double-dose #mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report

Immunogenicity, reactogenicity and #safety to assess #booster #vaccinations with #BNT162b2 or double-dose #mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report, etidiohnew.blogspot.com/2026/02/immu...

Effectiveness of #BNT162b2 and #mRNA-1273 #JN1-adapted #vaccines against #COVID19-associated #hospitalisation and #death ...

Effectiveness of #BNT162b2 and #mRNA-1273 #JN1-adapted #vaccines against #COVID19-associated #hospitalisation and #death ..., etidiohnew.blogspot.com/2025/07/effe...

📌 CoVacU18 -Studie: Daten zur Langzeitverträglichkeit des #COVID19-Impfstoffs #BNT162b2 bei Kindern

Langzeitverträglichkeit von BNT162b2 bei Kindern und Jugendlichen – Deutsches Ärzteblatt CoVacU18-Studie

Unsere 𝗖𝗼𝗩𝗮𝗰𝗨𝟭𝟴-𝗦𝘁𝘂𝗱𝗶𝗲 im Deutschen Ärzteblatt liefert Daten zur Langzeitverträglichkeit des #COVID19-Impfstoffs #BNT162b2 bei Kindern. Daten von 3.228 Teilnehmern systematisch ausgewertet.

👉🏻 »𝙏𝙝𝙚 𝙡𝙤𝙣𝙜-𝙩𝙚𝙧𝙢 𝙩𝙤𝙡𝙚𝙧𝙖𝙗𝙞𝙡𝙞𝙩𝙮 𝙤𝙛 𝘽𝙉𝙏162𝙗2 𝙞𝙣 𝙘𝙝𝙞𝙡𝙙𝙧𝙚𝙣 𝙖𝙣𝙙 𝙖𝙙𝙤𝙡𝙚𝙨𝙘𝙚𝙣𝙩𝙨«
🔗: www.aerzteblatt.de/archiv/langz...

Early #effectiveness of #BNT162b2 #KP2 #vaccine against #COVID19 in #US VA #Healthcare System

Early #effectiveness of #BNT162b2 #KP2 #vaccine against #COVID19 in #US VA #Healthcare System, etidiohnew.blogspot.com/2025/04/earl...

Surprisingly, comparative analysis revealed differential re-adenylation efficiency between vaccine formulations:
@biontech.bsky.social #Pfizer #BNT162b2 demonstrated reduced re-adenylation compared to mRNA-1273, correlating with diminished #ER membrane association. (13/n)

We studied three neuro events: #GBS, #myelitis and Bell's palsy and three vaccines: #ChAdOx1, #BNT162b2, mRNA-1273.

We found:
1) No link between the mRNA vaccines and the neuro events

2) Low rates of myelitis with no evidence of association with any of the three vaccines